Maternity Guidelines | WCH No. |
 ACC Maternal Birth Injuries | 2409745 |
| Admission to Primary Birthing Unit | GLM0044 |
| Analgesia Prescribing After Child Birth | GLM0069 |
| Antenatal Corticosteroid Therapy | GLM0065 |
| Antenatal Ultrasound for Obstetric Indications: Recommended Scan Frequency | GLM0006 |
| Antenatal Obstetric Ultrasound: Indications for Doppler | GLM0059 |
|
Antepartum Haemorrhage | GLM0052 |
| Anti D - Use of Rh(D) Immunoglobulin in Unsensitised Rhesus Negative Women | GLM0047 |
Birth After Previous Caesarean Section | GLM0017 |
|
Bladder Care: Intrapartum and Postnatal | GLM0038 |
|
Breech Birth | GLM0048 |
|
Caesarean Section: Antibiotic Prophylaxis | GLM0050 |
|
Caesarean Section Assisted Deliveries in Theatre | GLM0040 |
| Cervical Insufficiency | GLM0055 |
Cholestasis - Obstetric | GLM0005 |
|
Cord Prolapse | GLM0039 |
| COVID-19 Clinical Management in Hospitalised Adults (including in Pregnancy) | National Guideline |
| Diabetes in Pregnancy | National Guideline |
 Gestational Diabetes Screening, Diagnosis and Management: A Clinical Practice Guideline | National Guideline |
|
Diabetes - Gestational | GLM0025 |
| Diabetes - Gestational Antenatal Outpatient | GLM0071 |
Diabetes - Type 1 | GLM0024 |
Diabetes - Type 2 | GLM0023 |
| Diabetic Ketoacidosis Management in Pregnancy | GLM0061 |
| Insulin Infusion following Betamethasone Injections for Women with Diabetes in Pregnancy (C260117) | 2400756 |
|
Dural Puncture Accidental | GLM0008 |
|
Epidural Analgesia in Labour | GLM0007 |
External Cephalic Version | GLM0016 |
Fetal Heart Monitoring | GLM0010 |
| Fetal Movements | GLM0045 |
| Group-B Streptococcus - Management and Prophylactic Antibiotics in Labour | GLM0032 |
Herpes in pregnancy | 17th ed. 2017 |
|
Histological Examination of the Placenta | GLM0031 |
HIV Infected Women During Pregnancy and Childbirth | GLM0033 |
| Hyperemesis Gravidarum Patients: Enteral Feeding | 2410263 |
|
Hypoglycaemia of the Newborn | GLM0056 |
Induction of Labour
Please note this guideline is planned to be reviewed early 2023.
Please continue to refer to this guideline for operational detail and refer
to the Timing of Birth for Specific Obstetric Indications (TOBA)
guidelines 2022 and Prioritisation Tool: Induction of Labour for
recommendations/considerations on timing of birth and prioritising
of cases.
Please also refer to the National Induction of Labour guidelines for
additional information. | GLM0035 |
| Prioritisation Tool: Induction of Labour | 2409078 |
| Timing of Birth Obstetric Indications (TOBA) | 2409095 |
|
Oral Misoprostol Induction of Labour | |
| Induction of Labour Patient Information | 2400320 |
|
Misoprostol Induction of Labour Pathway | 2407461 |
|
In-Utero Transfer Between Hospitals | 2400256 |
Magnesium Sulphate for Neuroprotection in Preterm-Births | GLM0041 |
| Management of Suspected Small for Gestational Age Singleton Pregnancies After 34 Weeks Gestation | NZ Maternal Fetal Medicine Network |
Maternal Blood Optimisation Pathways (MBOP) Guideline and Practice Improvement Strategy
(also see MBOP section below) | GLM0070 |
|
Maternal Mental Health Pathway: Referral and Support Services in Canterbury | 2406554 |
| MDRO Admission Assessment Flowchart | 2404773 |
| Mental Health Medications in Pregnant and Breastfeeding Women | HealthPathways |
 Newborn Screening Guidelines | NSU website |
| Notifiable Diseases | HealthPathways |
| Observation of Mother and Baby in the Immediate Postnatal Period: Consensus Statements Guiding Practice | National Guideline
|
|
Opioid Use in Labour | GLM0053 |
| Periviability Consensus Statement | Starship |
|
Placenta Praevia and Placenta Accreta | GLM0002 |
|
Polyhydramnios | GLM0054 |
| Postpartum Haemorrhage Guideline for Treatment | National Guideline |
Postpartum Haemorrhage | GLM0021 |
Pre-Eclampsia and Eclampsia | GLM0003 |
|
Hypertension and Pre-eclampsia in Pregnancy in NZ | National Guideline |
Pre-Labour Rupture of Membranes at Term | GLM0043 |
Preterm Labour/Birth | GLM0027 |
Periviability Consensus Statement
Checklist: Antenatal care plan if at high risk of birth at 23 weeks to 24 weeks + 6 days
Parent Information: Shared decision making at 23 weeks and 24 weeks gestation | Starship 2406246
2406427 |
Preterm Pre-Labour Rupture of Membranes | GLM0028 |
|
Progress in Labour | GLM0062 |
| Referral/Transfer to Christchurch Women's Hospital from West Coast | GLM0063 |
Registrar Supervision | GLM0019 |
Maternity Referrals
| HealthPathways |
| Remifentanil Patient Controlled Analgesia for Labour | GLM0042 |
| Sepsis | GLM0072 |
| Sexually Transmitted Infection Guidelines | Just the Facts |
Shoulder Dystocia | GLM0011 |
| Substance Abuse in Pregnancy | GLM0067 |
| SUDI Prevention Safe Infant Sleep Policy | 2404926 |
| Swab and Instrument Counting Outside Theatre in the Maternity Setting | GLM0068 |
|
Syphilis in Pregnancy | NZSHS |
Tears: Third and Fourth Degree
| GLM0036 |
| Timing of Birth Obstetric Indications (TOBA) | 2409095 |
| Treating adults who decline blood products (including Jehovah's Witnesses) | Red book |
| Twin Pregnancy and Birth | GLM0064 |
| Venous Thromboembolism Prevention in the Postpartum | GLM0046 |
Water for Birth and Labour | GLM0037 |
| Zika Virus - Interim Guidance Information for LMC's, GP's and Other Health Professionals | |
Infant Feeding Policy and Guidelines | |
| Breastfeeding Policy | 2401341 |
| Breastfeeding Marketing Breastmilk Substitutes | GLB01a |
|
Breastfeeding Policy Communicated | GLB01b |
|
Breastfeeding Ongoing Monitoring | GLB01c |
|
Breastfeeding Education and Training | GLB02 |
|
Breastfeeding Antenatal Information | GLB03 |
|
Breastfeeding Skin-to-Skin | GLB04 |
|
Breastfeeding Support | GLB05 |
|
Breastfeeding Breastmilk for Newborns | GLB06 |
|
Breastfeeding Rooming In | GLB07 |
|
Breastfeeding Responsive Feeding | GLB08 |
|
Breastfeeding Bottles Teats and Pacifiers | GLB09 |
|
Breastfeeding Post Discharge Support | GLB10 |